Cellectar Biosciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

STOCK-BASED COMPENSATION (Tables)

v3.25.0.1

STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2024

STOCK-BASED COMPENSATION

Summary of the expense for stock-based compensation related to stock option grants


	Twelve Months Ended
	December 31,
	2024		2023
Employee and director stock option and stock grants:
Research and development	$	3,486,168	$	505,155
General and administrative		786,612		1,905,133
Total stock-based compensation	$	4,272,780	$	2,410,288

Schedule of assumptions used for stock


	Year Ended December 31,
	2024			2023
Volatility		82.13	%		82.02-83.28	%
Risk-free interest rate		4.21-4.64	%		3.59-4.68	%
Expected life (years)		6.0			6.0
Dividend		0	%		0	%

Summary of stock options activity


	Number of
	Shares
	Issuable			Weighted
	Upon			Average
	Exercise	Weighted		Remaining
	of	Average		Contracted	Aggregate
	Outstanding	Exercise		Term in	Intrinsic
	Options	Price		Years	Value
Outstanding as of December 31, 2022	746,257	$	13.48	8.58	$	—
Granted	1,617,000	$	1.78
Expired	(8)	$	8,325
Forfeited	(11,346)	$	1.92
Outstanding as of December 31, 2023	2,351,903	$	5.46	8.64	$	1,682,667
Granted	3,063,500	$	2.72
Expired	(1,614)	$	20.00
Exercised	(1,667)		1.68
Forfeited	(825,104)	$	2.51
Outstanding as of December 31, 2024	4,587,018	$	4.10	7.37	$	—

Exercisable as of December 31, 2024	2,933,097	$	3.69		$	—
Unvested as of December 31, 2024	1,653,921	$	2.19		$	—

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration